Drug targeting to specific vascular sites

Area of Science:

• Biochemistry
• Vascular Biology
• Oncology

Background:

• Tissue-specific blood vessels exhibit unique biochemical properties.
• Pathological conditions, such as tumors, alter vasculature, creating distinct molecular signatures.
• Tumor blood and lymphatic vessels differ significantly from those in healthy tissues.

Purpose of the Study:

• To identify and utilize unique vascular signatures in tumors for targeted therapy.
• To explore the potential of targeting diseased vasculature to enhance drug delivery and efficacy.
• To reduce systemic side effects associated with conventional therapeutic approaches.

Main Methods:

• Employing in vivo screening of phage libraries to discover peptides and antibodies recognizing specific vascular signatures.
• Developing targeted delivery systems for therapeutic agents based on identified vascular markers.
• Evaluating the efficacy and safety of targeted drug delivery in preclinical mouse models.

Main Results:

• Successful identification of peptides and antibodies that specifically recognize tumor vasculature.
• Demonstration of enhanced therapeutic agent delivery to tumor sites using targeted approaches.
• Significant improvements in treatment efficacy and reduction in side effects observed in mouse experiments.

Conclusions:

• Targeting unique vascular signatures in tumors is a viable strategy for enhancing drug delivery.
• Targeted therapies show promise in improving treatment outcomes for cancer while minimizing off-target toxicity.
• Further development of targeted delivery systems based on vascular signatures holds significant therapeutic potential.